Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
Latest press releases
- GSK showcases progress from the DREAMM clinical trial program in multiple myeloma at the 2021 ASH Annual Meeting
- GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment
- Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19
- GSK announces positive Phase III efficacy and safety data for daprodustat in patients with anaemia due to chronic kidney disease
GSK US Twitter
-
GSKUS @GSKUS
Judy Stewart, SVP and Head of US Vaccines, shares why it’s so important to improve routine immunization rates and address disparities in vaccination. Learn more in this clip and go Behind the science for the full video: gsk.to/3oXSMOD
about 6 days ago -
GSKUS @GSKUS
The first step towards managing #COPD is advocating for a better treatment plan – and it starts with reminding patients that they are not to blame for their diagnosis. This #COPDAwarenessMonth, learn more about how to #ShakeCOPDStigma:
about 6 days ago
-
GSK in the US
The US is home to ~15,000 GSK employees across 50 states, 9 manufacturing facilities and multiple R&D centers.
-
Pharmaceuticals
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
-
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
-
Consumer Healthcare
Consumer Healthcare develops brands in Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.
